SCHEMBL5117530

SCHEMBL5117530

CN(C)C(=O)C(N)Cc1ccc(Oc2ccc(C(N)=O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 16/20 0.53
PARP15 Q460N3 4/20 0.53
ALDH1A1 P00352 2/20 0.53
PARP14 Q460N5 2/20 0.53
PARP4 Q9UKK3 2/20 0.53
KMT2A Q03164 1/20 0.53
PARP16 Q8N5Y8 1/20 0.53
PARP11 Q9NR21 1/20 0.53
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PARP3 Q9Y6F1 1/20 0.44
PARP2 Q9UGN5 3/20 0.43
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
PARP1 P09874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14003044 0.85 HDAC6 (0.47) ALDH1A1OPRM1OPRK1HPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL4598799 0.84 HDAC6 (0.46) ALDH1A1OPRM1OPRK1HPGDSMN1; SMN2
SCHEMBL5130640 0.84 PARP10 (0.61) PARP10PARP15ALDH1A1PARP14PARP4
SCHEMBL14115837 0.84 FFAR1 (0.46) ALDH1A1OPRM1OPRD1OPRK1HPGD
SCHEMBL14021680 0.84 FFAR1 (0.46) ALDH1A1OPRM1OPRD1OPRK1HPGD
Hydrochloric Acid SCHEMBL4608479 0.83 FFAR1 (0.44) ALDH1A1OPRM1OPRD1OPRK1
SCHEMBL14115836 0.82 FFAR1 (0.57)
SCHEMBL14021677 0.82 FFAR1 (0.57)
Hydrochloric Acid SCHEMBL4596957 0.81 FFAR1 (0.56)
SCHEMBL14021723 0.79 ADRB2 (0.44) ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200521-A1 Novel hydroxamic acid containing amino acid derivatives BEXEL PHARMACEUTICALS. INC. 2008-08-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200521-A1 Novel hydroxamic acid containing amino acid derivatives HGFAC, HCAR2, BCAT1 PARP10 4008/4885PARP15 3465/4885ALDH1A1 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.